<!doctype html><html lang="zh-hans"><head><meta charset="utf-8"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>新的HIV疫苗具有97％的抗体反应率在I期人类试验中 New HIV vaccine with a 97% antibody response rate in phase I human trials</title><link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/css/bootstrap.min.css" integrity="sha384-ggOyR0iXCbMQv3Xipma34MD+dH/1fQ784/j6cY/iJTQUOhcWr7x9JvoRxT2MZw1T" crossorigin="anonymous"><link rel="stylesheet" href="/img/css.css?random="><link data-rh="true" rel="icon" href="/img/favicon.ico"/><script data-ad-client="ca-pub-6067137220025946" async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script><script type="text/javascript" src="https://platform-api.sharethis.com/js/sharethis.js#property=5effb96910009800120b8d4d&product=inline-share-buttons" async="async"></script>
<script>var _hmt = _hmt || [];(function() {var hm = document.createElement("script");hm.src = "https://hm.baidu.com/hm.js?03c1a0f31299b4a2fbb83c34d6beaac9";var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s);})();</script></head><body><div id="my_header"><div class="container"><nav class="navbar navbar-expand-lg"><a class="navbar-brand" href="/"><img alt="diglog" src="/img/logo.v1.gif" class="rounded-sm"></a><button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarNavAltMarkup" aria-controls="navbarNavAltMarkup" aria-expanded="false" aria-label="Toggle navigation"><span class="navbar-toggler-icon"></span></button><div class="collapse navbar-collapse" id="navbarNavAltMarkup"><div class="navbar-nav"></div></div></nav></div></div><div class="container"><div id="my_content"><h1 class="page_narrow">New HIV vaccine with a 97% antibody response rate in phase I human trials<br/>新的HIV疫苗具有97％的抗体反应率在I期人类试验中 </h1><div class="row"><div class="col-lg-12 col-12"><div class="my_story_list_item shadow p-3 mb-5 bg-white rounded"><div class="story_page_pub_time page_narrow">2021-04-05 03:52:50</div><div class="story_img_container"><a href="http://img2.diglog.com/img/2021/4/16c0309ebffef9179903767bda1d1464.jpg"><img src="http://img2.diglog.com/img/2021/4/16c0309ebffef9179903767bda1d1464.jpg" class="img-fluid my_story_img" onerror="this.style.display='none'"></a></div><div class="page_narrow text-break page_content"><p>The vaccine was able to target the desired immune cells and could become the first stage of a multi-step vaccine strategy to combat HIV and various other viral diseases.</p><p>疫苗能够靶向所需的免疫细胞，并且可以成为对抗艾滋病毒和各种其他病毒疾病的多步疫苗策略的第一阶段。</p><p>  A novel vaccine approach for the prevention of HIV has shown promise in Phase I trials, reported  IAVI and  Scripps Research. According to the organisations, the vaccine successfully stimulated the production of the rare immune cells needed to generate antibodies against HIV in 97 percent of participants.</p><p>  预防艾滋病毒的新型疫苗方法表明了IAVI和Scripps Research的阶段试验中的承诺。根据组织，疫苗成功地刺激了在97％的参与者中产生针对艾滋病毒的抗体所需的罕见免疫细胞。</p><p> The vaccine is being developed to act as an immune primer, to trigger the activation of naïve B cells via a process called germline-targeting, as the first stage in a multi-step vaccine regimen to elicit the production of many different types of broadly neutralizing antibodies (bnAbs). Stimulating the production of bnAbs has been pursued as a holy grail in HIV for decades. It is hoped that these specialised blood proteins could attach to HIV surface proteins called spikes, which allow the virus to enter human cells, and disable them via a difficult-to-access regions that does not vary much from strain to strain.</p><p> 正在开发疫苗以充当免疫引物，以通过称为种系靶向的方法引发幼稚B细胞的活化，作为一种多步疫苗方案中的第一阶段，以引发许多不同类型的宽度中和的生产抗体（Bnabs）。刺激BNAB的生产已被追求为艾滋病毒的圣杯。希望这些专业的血液蛋白质可以附着于称为尖峰的HIV表面蛋白质，使病毒进入人体细胞，并通过难以进入的区域禁用它们不会从菌株变化的难以变化。</p><p> “We and others postulated many years ago that in order to induce bnAbs, you must start the process by triggering the right B cells – cells that have special properties giving them potential to develop into bnAb-secreting cells,” explained Dr William Schief, a professor and immunologist at Scripps Research and executive director of vaccine design at IAVI’s Neutralizing Antibody Center, whose laboratory developed the vaccine. “In this trial, the targeted cells were only about one in a million of all naïve B cells. To get the right antibody response, we first need to prime the right B cells. The data from this trial affirms the ability of the vaccine immunogen to do this.”</p><p> “我们和其他多年前假释的是，为了诱导BNAB，您必须通过触发具有特殊属性的右b细胞来开始该过程，使其能够发展成为BNAB分泌细胞的潜力，”威廉希切尔博士解释说Iavi中和抗体中心扰动研究和疫苗设计疫苗设计的教授和免疫学家，其实验室开发了疫苗。 “在该试验中，靶向细胞仅为百万分之一的所有Naïveb细胞。为了获得正确的抗体反应，我们首先需要赋予右b细胞。来自该试验的数据肯定了疫苗免疫原做的能力。“</p><p>  Schief presented the results at the International AIDS Society HIV Research for Prevention (HIVR4P) virtual conference on Wednesday 3 February.</p><p>  Schief在2月3日星期三的预防（HIVR4P）虚拟会议上的国际艾滋病社会艾滋病毒研究结果提出了结果。</p><p> In the Phase I IAVI G001trial, 48 healthy adult volunteers were enrolled to receive either a placebo or two doses of the vaccine compound, eOD-GT8 60mer, along with an adjuvant developed by the GlaxoSmithKline.</p><p> 在I IAVI G001trial中，48个健康的成人志愿者注册了疫苗化合物，EOD-GT8 60mer的安慰剂或两剂，以及由Glaxosmithkline开发的佐剂。</p><p> One of the lead investigators on the trial, Dr Julie McElrath, senior vice president and director of Fred Hutch’s Vaccine and Infectious Disease Division, said the trial was “a landmark study in the HIV vaccine field,” adding that they had demonstrated “success in the first step of a pathway to induce broad neutralising antibodies against HIV-1.”</p><p> 审判的主要调查人员之一，朱莉麦克拉斯博士，弗雷德·哈克斯疫苗和传染病师总监司令部博士表示，该试验是“艾滋病病毒疫苗领域的着色研究，”加入他们已经证明“成功途径诱导宽度中和抗体抗HIV-1的第一步。“ </p><p> HIV affects more than 38 million people globally and is among the most difficult viruses to target with a vaccine, in large part because of its unusually fast mutation rate which allows it to constantly evolve and evade the immune system.</p><p>艾滋病毒在全球范围内影响了超过3800万人，并且在很大程度上是由于其异常快速的突变率，这是一种疫苗的最困难的病毒，这使得它不断地发展和避免免疫系统。</p><p> Dr Schief commented: “This study demonstrates proof of principle for a new vaccine concept for HIV, a concept that could be applied to other pathogens as well. With our many collaborators on the study team, we showed that vaccines can be designed to stimulate rare immune cells with specific properties and this targeted stimulation can be very efficient in humans. We believe this approach will be key to making an HIV vaccine and possibly important for making vaccines against other pathogens.”</p><p> Schief博士评论说：“本研究表明，对于艾滋病毒的新疫苗概念，一种可以应用于其他病原体的概念的原则证明。在研究团队的许多合作者中，我们展示了疫苗可以设计用于刺激具有特异性特性的稀有免疫细胞，并且这种有针对性的刺激可以在人类中非常有效。我们认为这种方法将是制备艾滋病毒疫苗的关键，并且对其他病原体进行疫苗可能是重要的。“</p><p> The company’s said this study sets the stage for additional clinical trials that will seek to refine and extend the approach, with the long-term goal of creating a safe and effective HIV vaccine. As a next step, the collaborators are partnering with the biotechnology company Moderna to develop and test an mRNA-based vaccine that harnesses the approach to produce the same beneficial immune cells. According to the team, using mRNA technology could significantly accelerate the pace of HIV vaccine development, as it did with vaccines for COVID-19.</p><p> 该研究所述研究设定了额外的临床试验的阶段，该临床试验将寻求改进和扩展方法，具有创造安全和有效的艾滋病毒疫苗的长期目标。作为下一步，合作者正在与生物技术公司现代人合作，开发和测试基于mRNA的疫苗，这些疫苗利用产生相同的有益免疫细胞的方法。根据该团队的说法，使用MRNA技术可以显着加速HIV疫苗开发的速度，因为它对Covid-19的疫苗进行了疫苗。</p><p> “This is a tremendous achievement for vaccine science as a whole,” said Dr Dennis Burton, professor and chair of the Department of Immunology and Microbiology at Scripps Research, scientific director of the IAVI Neutralizing Antibody Center and director of the NIH Consortium for HIV/AIDS Vaccine Development. “This clinical trial has shown that we can drive immune responses in predictable ways to make new and better vaccines, and not just for HIV. We believe this type of vaccine engineering can be applied more broadly, bringing about a new day in vaccinology.”</p><p> “这是一体的疫苗科学巨大成就，”Scrips Research的Iavi中和抗体中心和NIH联盟的NIH联盟主任的Scripces Research of Scripces Research博士博士博士和董事长Dennis Burton博士和主席。艾滋病疫苗开发。 “这种临床试验表明，我们可以以可预测的方式推动免疫反应，以制作新的和更好的疫苗，而不仅仅是为了艾滋病毒。我们认为这种类型的疫苗工程可以更广泛地应用，在疫苗学中带来新的一天。“</p><p> The scientists believe the same approach could also be applied to vaccines for other challenging pathogens such as influenza, dengue, Zika, hepatitis C and malaria.</p><p> 科学家认为，相同的方法也可以应用于其他挑战性病原体，如流感，登革热，Zika，丙型肝炎和疟疾等其他挑战性病原体。 </p></div><div id="story_share_this"><div class="sharethis-inline-share-buttons"></div></div><div class="text-break sotry_link page_narrow"><a target="_blank" href="https://www.europeanpharmaceuticalreview.com/news/141892/novel-hiv-vaccine-approach-shows-promise-in-landmark-first-in-human-trial/">https://www.europeanpharmaceuticalreview.com/news/141892/novel-hiv-vaccine-approach-shows-promise-in-landmark-first-in-human-trial/</a></div><div class="story_tags page_narrow"><button type="button" class="btn btn-light my_tag"><a href="/tag/疫苗/">#疫苗</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/response/">#response</a></button></div></div><div class="my_movie_list_item shadow p-3 mb-5 bg-white rounded"><button type="button" class="btn btn-link my_tag"><a href="/tag/web2.0/">#web2.0</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/google/">#google</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/设计/">#设计</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/创意/">#创意</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/摄影/">#摄影</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/图片/">#图片</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/游戏/">#游戏</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/软件/">#软件</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/视频/">#视频</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/手机/">#手机</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/广告/">#广告</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/iphone/">#iphone</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/网站/">#网站</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/免费/">#免费</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/下载/">#下载</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/windows/">#windows</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/微软/">#微软</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/firefox/">#firefox</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/blog/">#blog</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/音乐/">#音乐</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/apple/">#apple</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/博客/">#博客</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/苹果/">#苹果</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/wordpress/">#wordpress</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/恶搞/">#恶搞</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/qq/">#qq</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/艺术/">#艺术</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/谷歌/">#谷歌</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/web/">#web</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/工具/">#工具</a></button></div></div></div><div id="my_footer"><div class=""><a href="/tags/">tags</a> <a href="/users/">users</a></div>&copy;2012-2021 diglog.com </div></div></body></html>